TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.
Also called NCT02505399
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 180 participants
- Registry
-
NCT02505399
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT02505399. Randomized; double masking; primary purpose prevention. Start 2015-11 (registry gives no type); primary completion 2018-05-24 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement
- Acronym
- TIRATROP
- Condition
- Atherosclerosis
- Intervention (Drug)
- ticagrelor
- Intervention (Drug)
- clopidogrel
- Lead sponsor
- University Hospital, Toulouse
Record details
- Record id
cardio:ct-nct02505399- Content hash
392b4ba6c93ddf242790c5f8ff778f4944b6e40f2c9c9f20a84bc6a4eff966df